📰 5 sources covering this story

STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more

First covered 1 days ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more
STAT News
STAT News1 hrs ago
STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more
Roche's Genentech will invest $750 million to double the size of its existing production facility in Oregon
RTÉ News
RTÉ News20 hrs ago
Rare disease drug recalled in Ireland after Japan deaths
A drug used to treat rare autoimmune diseases has been pulled from shelves in Ireland after it was linked to 20 deaths in Japan.
France recalls rare disease drug Tavneos after deaths in Japan
France's medicine safety agency announced Wednesday the drug, which is used to treat rare autoimmune diseases, would be withdrawn after it was linked to a series of death in Japan.
Le Monde
Le Monde1 days ago
France recalls rare disease drug Tavneos after deaths in Japan
France's medicine safety agency announced Wednesday the drug, which is used to treat rare autoimmune diseases, would be withdrawn after it was linked to a series of death in Japan.
The Local France
The Local France🏁 first to report1 days ago
France recalls rare disease drug Tavneos after deaths
A drug called Tavneos used to treat rare autoimmune diseases will be pulled from the shelves in France, the country's medicine watchdog said Wednesday, after it was linked to 20 deaths in Japan.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →